Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Lenk, R; Likar, R.
[Cannabinoids in medicine].
Wien Med Wochenschr. 2008; 158(23-24): 668-73.
Doi: 10.1007/s10354-008-0619-7
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Likar Rudolf
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Cannabinoids have been known for many centuries because of their various effects in healthcare. They are primarily effective in reducing nausea, vomiting, pain, anorexia, spasticity and depression. Some other effects are known, all seem to be mediated by cannabinoid receptors in the central nervous system. In the past years, medical use has been proven in several studies. Today, the therapeutical use of cannabinoids in medicine is increasing, and access was made easier. Especially in pain-management and palliative care, they seem to be a valuable therapeutic option.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adenocarcinoma - physiopathology, psychology
-
Analgesics - therapeutic use
-
Analgesics, Opioid - therapeutic use
-
Dronabinol - adverse effects, analogs & derivatives, therapeutic use
-
Drug Therapy, Combination - administration & dosage
-
Female - administration & dosage
-
Humans - administration & dosage
-
Middle Aged - administration & dosage
-
Multiple Sclerosis - physiopathology, psychology
-
Pain, Intractable - drug therapy, psychology
-
Palliative Care - methods
-
Quality of Life - psychology
-
Uterine Neoplasms - physiopathology, psychology